Top Markets
#1 Islamic Coin Islamic Coin +151.51%
#2 Akedo Akedo +65.07%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +50.07%
#5 Velvet Velvet +44.04%
#6 Black Phoenix Black Phoenix +34.24%
#7 Cross Cross +27.93%
#8 Cap Cap +17.71%
#9 DoubleZero DoubleZero +14.64%
#10 Pieverse Pieverse +10.18%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.

NeuBase Therapeutics, Inc.

NBSE
Classement en actions #39175
Operating as a pre-clinical biopharmaceutical company, NeuBase Therapeutics,... Operating as a pre-clinical biopharmaceutical company, NeuBase Therapeutics, Inc. is dedicated to pioneering therapeutic solutions for rare genetic disorders and various cancers stemming from aberrant genes. At the core of its approach is the proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform. This technology is being utilized to target ailments such as Huntington's disease (HD) and myotonic dystrophy, in addition to a broader spectrum of genetic conditions and applications within oncology. The company's leading therapeutic candidates encompass NT0100, a PATrOL-powered anti-gene therapy for Huntington's disease; NT0200, another PATrOL-enabled anti-gene solution for myotonic dystrophy type 1; and NT0300, a PATrOL-based treatment specifically engineered to address the mutated KRAS gene. NeuBase Therapeutics, Inc. maintains its headquarters in Pittsburgh, Pennsylvania.
Prix de l'action
$0.378
Dernière synchronisation: 2024-05-24
Capitalisation boursière
$618.41K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange NeuBase Therapeutics, Inc. (NBSE)

Catégorie

Healthcare
Le prix NBSE avec la capitalisation boursière de B
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
NBSE
$0.378
Capitalisation boursière de NeuBase Therapeutics, Inc.(NBSE)
Capitalisation boursière: $618.41K
En August 2026, NeuBase Therapeutics, Inc. a une capitalisation boursière de $618.41K. Cela fait de NeuBase Therapeutics, Inc. la 39175th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de NeuBase Therapeutics, Inc. du 2004 au 2026
NBSE par rapport au top 5 des plus populaires stocks
Prix pour NBSE L’actif B La capitalisation boursière de B Résultats
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$3,343,238 $618.41K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.470T +884,454,463.65%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$2,730,484 $618.41K
Apple Inc. Apple Inc.
AAPL
$4.467T +722,350,064.17%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$2,551,581 $618.41K
Alphabet Inc. Alphabet Inc.
GOOG
$4.174T +675,021,304.38%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$2,261,661 $618.41K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +598,322,901.89%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$1,744,708 $618.41K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.854T +461,562,929.50%